ClinicalTrials.gg
Not yet recruitingNCT06692660ELIPSEUpdated Nov 18, 2024

Overview: Use of Respiratory Support At Home in Children

An observational study in Sleep Apnea Syndromes in Children, Obesity in Children and Bronchopulmonary Dysplasia (BPD), sponsored by University Hospital, Grenoble. Not yet recruiting at 2 sites in France. Open to participants aged 0 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-11-18.

Sponsored by University Hospital, Grenoble · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Ages
0 Years to 17 Years
Sex
All
01

Study summary

the primary outcome is to describe the perceived success of the use of the respiratory support from the parent's point of view

Read the detailed description

The use of ventilatory support, including CPAP (Continuous Positive Airway Pressure), which is a mode of ventilation with continuous positive pressure, and BiPAP (Bilevel Positive Airway Pressure), which is a mode of ventilation with two levels of pressure, has seen a significant increase in indications in recent years. The indications have become more numerous and increasingly complex. Sleep-related respiratory disorders, including obstructive sleep apnea-hypopnea syndrome, central apnea syndrome, and alveolar hypoventilation, are the primary reasons for these indications. In pediatrics, numerous conditions contribute to sleep-related respiratory disorders: ENT malformations, genetic conditions, obesity, bronchopulmonary dysplasia, neuromuscular diseases, thoracic deformities, and storage diseases.

The non-use or insufficient use of ventilatory support leads to a lack of treatment for sleep-related respiratory disorders. In the absence of treatment, the consequences are neurocognitive, cardiovascular, and metabolic, resulting in high morbidity. Non-use or insufficient use is a cause of failure of ventilatory support. Neither the use nor the failure of ventilatory support is clearly defined. It is crucial to evaluate the use of ventilatory support in order to correct factors related to non-use or insufficient use and to prevent the negative consequences resulting from unaddressed sleep-related respiratory disorders. This pilot study aims to assess the use of ventilatory support at home in pediatrics through interviews with patients and their parents. We will use a questionnaire designed for the study, consisting of 10 questions regarding sleep, symptoms, quality of life, technical issues, side effects, economic barriers, and adherence, to describe their experiences with ventilatory support.

02

Conditions studied

  • Sleep Apnea Syndromes in Children
  • Obesity in Children
  • Bronchopulmonary Dysplasia (BPD)
  • Neuromuscular Disease
  • Storage Disease
  • Malformation
  • Alveolar Hypoventilation

Keywords

  • respiratory suport
  • sleep apnea syndrome
  • CPAP
  • BiPAP
  • ventilation
  • alveolar hypoventilation
  • non invasive ventilation
03

In context

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

This study's planned enrollment of 30 is below the median of 180 across 235 observational studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 837 studies on the registry; 207 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Our study population includes patients from the Grenoble Alpes Hospital, from 0 to 18 (not yet passed) years old. These patients benefit from respiratory support at home. Their follow-up is done at the Grenoble Alpes Hospital. We will not include patients who benefit from palliative care, invasive ventilation or high flow oxygen therapy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children with respiratory support at home
  • Age 0 to 18 (not yet passed) years old

Exclusion criteria

Exclusion Criteria:

  • Palliative care
  • Invasive ventilation
  • High flow oxygen therapy
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. describe the perceived success of the use of the respiratory support from the parent's point of view

    The primary outcome measure is the median score and interquartile range, obtained from the answer modalities according to the Likert scale (scores ranging from 1 to 5), in response to the question from the parent interview guide, which states: "Do you consider that the ventilatory support proposed for your child is a success? Please circle the corresponding score."

    Time frame: Assessment during the filling of the questionnaire at enrollment

Secondary outcomes

  1. Describe the persistence of symptoms under ventilatory support according to the parent.

    Answer to the question from the parent interview guide: "What symptoms did your child have before starting treatment? Have these symptoms improved?"

    Time frame: Assessment during the filling of the questionnaire at enrollment

  2. Describe the persistence of symptoms under ventilatory support according to the child

    Answer to the question from the child interview guide: "Were you bothered before getting the machine? Is it better with the machine?"

    Time frame: Assessment during the filling of the questionnaire at enrollment

  3. Describe the tolerance of ventilatory support according to the parent.

    Answer to the question from the parent interview guide: "Have you noticed any complications since your child started using the machine?"

    Time frame: Assessment during the filling of the questionnaire at enrollment

  4. Describe the tolerance of ventilatory support according to the child.

    Answer to the question from the child interview guide: "Does the machine bother you?"

    Time frame: Assessment during the filling of the questionnaire at enrollment

  5. Describe adherence to ventilatory support according to the parent.

    Answer to the question from the parent interview guide: "How many hours does your child use the machine at night? How many nights per week? Does your child use the machine when you go away for the weekend or on vacation...? If not, why?" For children aged 0-4 years: "Does the child wear it during naps? How many naps per week?"

    Time frame: Assessment during the filling of the questionnaire at enrollment

  6. Describe adherence to ventilatory support according to the child.

    Answer to the question from the child interview guide: "Can you wear your machine all night? Every night? Do you wear your machine when you're not sleeping at home? If not, why? "

    Time frame: Assessment during the filling of the questionnaire at enrollment

07

Study locations

2 sites
08

References and documents

Publications

  • Amaddeo A, Khirani S, Griffon L, Teng T, Lanzeray A, Fauroux B. Non-invasive Ventilation and CPAP Failure in Children and Indications for Invasive Ventilation. Front Pediatr. 2020 Oct 26;8:544921. doi: 10.3389/fped.2020.544921. eCollection 2020. PubMed 33194886 ↗
  • MacLean JE, Fauroux B. Long-term non-invasive ventilation in children: Transition from hospital to home. Paediatr Respir Rev. 2023 Sep;47:3-10. doi: 10.1016/j.prrv.2023.01.002. Epub 2023 Jan 12. PubMed 36806331 ↗
  • Ramirez A, Delord V, Khirani S, Leroux K, Cassier S, Kadlub N, Aubertin G, Picard A, Fauroux B. Interfaces for long-term noninvasive positive pressure ventilation in children. Intensive Care Med. 2012 Apr;38(4):655-62. doi: 10.1007/s00134-012-2516-1. Epub 2012 Mar 6. PubMed 22392032 ↗
  • McLaren AT, Bin-Hasan S, Narang I. Diagnosis, management and pathophysiology of central sleep apnea in children. Paediatr Respir Rev. 2019 Apr;30:49-57. doi: 10.1016/j.prrv.2018.07.005. Epub 2018 Jul 25. PubMed 30170958 ↗
  • Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, Schechter MS, Sheldon SH, Spruyt K, Ward SD, Lehmann C, Shiffman RN; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):576-84. doi: 10.1542/peds.2012-1671. Epub 2012 Aug 27. PubMed 22926173 ↗
  • Ramirez A, Khirani S, Aloui S, Delord V, Borel JC, Pepin JL, Fauroux B. Continuous positive airway pressure and noninvasive ventilation adherence in children. Sleep Med. 2013 Dec;14(12):1290-4. doi: 10.1016/j.sleep.2013.06.020. Epub 2013 Sep 25. PubMed 24157098 ↗
  • Bhattacharjee R, Benjafield AV, Armitstead J, Cistulli PA, Nunez CM, Pepin JD, Woehrle H, Yan Y, Malhotra A; medXcloud group. Adherence in children using positive airway pressure therapy: a big-data analysis. Lancet Digit Health. 2020 Feb;2(2):e94-e101. doi: 10.1016/S2589-7500(19)30214-6. Epub 2019 Dec 23. Erratum In: Lancet Digit Health. 2020 Sep;2(9):e455. doi: 10.1016/S2589-7500(20)30195-3. PubMed 33334566 ↗
  • Amaddeo A, Frapin A, Fauroux B. Long-term non-invasive ventilation in children. Lancet Respir Med. 2016 Dec;4(12):999-1008. doi: 10.1016/S2213-2600(16)30151-5. Epub 2016 Jul 13. PubMed 27423917 ↗
  • Fauroux B, Abel F, Amaddeo A, Bignamini E, Chan E, Corel L, Cutrera R, Ersu R, Installe S, Khirani S, Krivec U, Narayan O, MacLean J, Perez De Sa V, Pons-Odena M, Stehling F, Ferreira RT, Verhulst S. ERS statement on paediatric long-term noninvasive respiratory support. Eur Respir J. 2022 Jun 2;59(6):2101404. doi: 10.1183/13993003.01404-2021. Print 2022 Jun. PubMed 34916265 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06692660
Responsible party
Sponsor
First posted
Nov 18, 2024
Start date
Nov 2024 (estimated)
Primary completion
Aug 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Nov 18, 2024

Study contacts

Julie CASSIBBA, MD
Contact
jcassibba@chu-grenoble.fr
+33476765566
Camille BERTIN, Intern
Contact
cbertin1@chu-grenoble.fr
+33660676532

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion